Literature DB >> 30066080

Clinical Use of Digitalis: A State of the Art Review.

Thomas F Whayne1.   

Abstract

The history of digitalis is rich and interesting, with the first use usually attributed to William Withering and his study on the foxglove published in 1785. However, some knowledge of plants with digitalis-like effects used for congestive heart failure (CHF) was in evidence as early as Roman times. The active components of the foxglove (Digitalis purpurea and Digitalis lanata) are classified as cardiac glycosides or cardiotonic steroids and include the well-known digitalis leaf, digitoxin, and digoxin; ouabain is a rapid-acting glycoside usually obtained from Strophanthus gratus. These drugs are potent inhibitors of cellular membrane sodium-potassium adenosine triphosphatase (Na+/K+-ATPase). For most of the twentieth century, digitalis and its derivatives, especially digoxin, were the available standard of care for CHF. However, as the century closed, many doubts, especially regarding safety, were raised about their use as other treatments for CHF, such as decreasing the preload of the left ventricle, were developed. Careful attention is needed to maintain the serum digoxin level at ≤ 1.0 ng/ml because of the very narrow therapeutic window of the medication. Evidence for benefit exists for CHF with reduced ejection fraction (EF), also referred to as heart failure with reduced EF (HFrEF), especially when considering the combination of mortality, morbidity, and decreased hospitalizations. However, the major support for using digoxin is in atrial fibrillation (AF) with a rapid ventricular response when a rate control approach is planned. The strongest support of all for digoxin is for its use in rate control in AF in the presence of a marginal blood pressure, since all other rate control medications contribute to additional hypotension. In summary, these days, digoxin appears to be of most use in HFrEF and in AF with rapid ventricular response for rate control, especially when associated with hypotension. The valuable history of the foxglove continues; it has been modified but not relegated to the garden or the medical history book, as some would advocate.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30066080     DOI: 10.1007/s40256-018-0292-1

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN: 1175-3277            Impact factor:   3.571


  20 in total

Review 1.  Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.

Authors:  Jianbo Zhou; Li Wang; Cheng Peng; Fu Peng
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

Review 2.  GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review.

Authors:  Roberto De Masi; Stefania Orlando
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 3.  A Complete Review of Mexican Plants with Teratogenic Effects.

Authors:  Germán Chamorro-Cevallos; María Angélica Mojica-Villegas; Yuliana García-Martínez; Salud Pérez-Gutiérrez; Eduardo Madrigal-Santillán; Nancy Vargas-Mendoza; José A Morales-González; José Melesio Cristóbal-Luna
Journal:  Plants (Basel)       Date:  2022-06-24

4.  Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia.

Authors:  Mumin Alper Erdogan; Mehmet Kirazlar; Gurkan Yigitturk; Oytun Erbas
Journal:  Neurochem Res       Date:  2022-01-21       Impact factor: 3.996

5.  The inotropic agent digitoxin strengthens desmosomal adhesion in cardiac myocytes in an ERK1/2-dependent manner.

Authors:  Camilla Schinner; Silvana Olivares-Florez; Angela Schlipp; Sebastian Trenz; Manouk Feinendegen; Heinrich Flaswinkel; Ellen Kempf; Desalegn Tadesse Egu; Sunil Yeruva; Jens Waschke
Journal:  Basic Res Cardiol       Date:  2020-06-17       Impact factor: 17.165

Review 6.  Unbalance Between Sarcoplasmic Reticulum Ca2 + Uptake and Release: A First Step Toward Ca2 + Triggered Arrhythmias and Cardiac Damage.

Authors:  Marilén Federico; Carlos A Valverde; Alicia Mattiazzi; Julieta Palomeque
Journal:  Front Physiol       Date:  2020-01-23       Impact factor: 4.566

7.  Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds.

Authors:  Awet Alem Teklemichael; Shusaku Mizukami; Kazufumi Toume; Farhana Mosaddeque; Mohamed Gomaa Kamel; Osamu Kaneko; Katsuko Komatsu; Juntra Karbwang; Nguyen Tien Huy; Kenji Hirayama
Journal:  Malar J       Date:  2020-06-08       Impact factor: 2.979

8.  Cardiac glycosides are broad-spectrum senolytics.

Authors:  Ana Guerrero; Nicolás Herranz; Bin Sun; Verena Wagner; Suchira Gallage; Romain Guiho; Katharina Wolter; Joaquim Pombo; Elaine E Irvine; Andrew J Innes; Jodie Birch; Justyna Glegola; Saba Manshaei; Danijela Heide; Gopuraja Dharmalingam; Jule Harbig; Antoni Olona; Jacques Behmoaras; Daniel Dauch; Anthony G Uren; Lars Zender; Santiago Vernia; Juan Pedro Martínez-Barbera; Mathias Heikenwalder; Dominic J Withers; Jesús Gil
Journal:  Nat Metab       Date:  2019-10-21

9.  In meso crystallogenesis. Compatibility of the lipid cubic phase with the synthetic digitonin analogue, glyco-diosgenin.

Authors:  Leendert van Dalsen; Dietmar Weichert; Martin Caffrey
Journal:  J Appl Crystallogr       Date:  2020-03-25       Impact factor: 3.304

Review 10.  Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.

Authors:  Catherine S Adamson; Michael M Nevels
Journal:  Viruses       Date:  2020-01-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.